Company research
Lumexa Imaging Holdings, Inc.
CIK 2071288Updated Nov 14, 2026
SecurityLMRI · NASDAQ · equity
LMRI price & chart
Loading TradingView…
NASDAQ:LMRI on TradingView ↗About the company
Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team members and approximately 190 outpatient imaging centers, our team conducted approximately 4 million outpatient procedures system-wide in 2025. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.
In the news
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date ↗
Seeking Alpha
Lumexa outlines at least 30% 2026 free cash flow conversion while targeting roughly $77B total addressable market ↗
Lumexa Imaging Holdings, Inc. (LMRI) Q3 2026 Earnings Call Transcript ↗
Lumexa Imaging Holdings, Inc. Non-GAAP EPS of $0.26 beats by $0.08, revenue of $272M beats by $2.11M ↗
SEC disclosures
Lumexa Imaging Holdings, Inc. files 8-K: Material Event ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
Show 5 more recent filings
Submission of Matters to a Vote of Security Holders
Items 5.07, 9.01
4 filing
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
ARS filing
Filing attachments
d101681dex991.htm · 8-K · 2026-11-10
Exhibit 99.1 Lumexa Imaging Announces Third Quarter 2026 Results RALEIGH, N. C., November 10, 2026 - Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the third quarter ended September 30, 2026. “In Q3, we advanced our business in several meaningful ways while executing against our strategy. Advanced modalities reached a record high as a percent of our volumes, and our newer de novo cohorts continue to ramp on plan.…
Read attachment ↗d113773dex991.htm · 8-K · 2026-08-12
EX-99.1 2 d113773dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Lumexa Imaging Announces Second Quarter 2026 Results RALEIGH, N. C., August 12, 2026 - Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the second quarter ended June 30, 2026, and updated its full year 2026 outlook. “During the second quarter, we continued to build on our momentum, delivering strong same-center growth, expanding our mix of advanced imagi…
Read attachment ↗d145661dex991.htm · 8-K · 2026-05-12
EX-99.1 2 d145661dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Lumexa Imaging Announces First Quarter 2026 Results RALEIGH, NORTH CAROLINA, May 12, 2026 - Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance. “In Q1, we delivered several meaningful achievements to kick off a year of executing on our strategic priorities.” said Caitlin Zulla,…
Read attachment ↗d138307dex991.htm · 8-K · 2026-03-26
EX-99.1 2 d138307dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance RALEIGH, NORTH CAROLINA, March 26, 2026 - Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced certain financial results for the fourth quarter ended December 31, 2025, and reiterated full year 2026 guidance. The financial results included in this release pertaining to…
Read attachment ↗